http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3171872-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b0bb3e5b3d6a4b3082dab3ed0fde62e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 2015-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_253d04fb5847f8801df46dfff890ec46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ad3554edbaedb6f485ee99a52596259
publicationDate 2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3171872-A1
titleOfInvention Method for treating radiotherapy-and-chemotherapy associated cognitive or emotional impairment with cannabinoids
abstract A method for treating radiotherapy - or chemotherapy - induced cognitive or emotional impairment by topically administering a cannabinoid. The cannabinoid is topically administered to an area of the face of the subject not including the palpebral part of the eye or to the back of the neck. To meet this need, a method for treating radiotherapy- or chemotherapy - associated cognitive or emotional impairment is provided. The method includes topically administering to a subject an effective amount of a composition containing a cannabinoid.
priorityDate 2014-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226503932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226503933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427651
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226595762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5394
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5712057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID34180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226724848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395940

Total number of triples: 49.